Special offersSpecial offers
AntiviralsAntivirals
Famvir Generic Famvir
Famciclovir 250mg
BUY NOWBUY NOW $3.00 Per pill
Lamprene Generic Lamprene
Clofazimine 50mg
BUY NOWBUY NOW $2.75 Per pill
Rebetol Generic Rebetol
Ribavirin 200mg
BUY NOWBUY NOW $7.50 Per pill
Relenza Generic Relenza
Zanamivir 5mg
BUY NOWBUY NOW $149.98 Per item
Symmetrel Generic Symmetrel
Amantadine 100mg
BUY NOWBUY NOW $1.11 Per pill
Tamiflu Generic Tamiflu
Oseltamivir 75mg
BUY NOWBUY NOW $8.00 Per pill
Valtrex Generic Valtrex
Valacyclovir 0.5/1g
BUY NOWBUY NOW $5.22 Per pill
Zovirax Generic Zovirax
Acyclovir 200/400/800mg
BUY NOWBUY NOW $0.64 Per pill
Search for pillsSearch for pills

TestimonialsTestimonials
I received a partial shipment yesterday.
The pills have always worked very well...as expected.
That's why I ordered from you again this year...just like last year.
In fact, yours work better than the 50 mg brand name pills I still have!!
An since your pills are scored (unlike the brand name ones that I have to use a knife to split), I can easily lower the dosage to 25 mg...which is all I need.
Thank you for a great product at a reasonable price!
Read more »Read more »
NewsNews
    Public weighs in on pandemic antiviral distribution - CIDRAP
    Public weighs in on pandemic antiviral distributionCIDRAPMay 18, 2012 (CIDRAP News) – The Institute of Medicine (IOM) yesterday shared findings of three public opinion panels on antiviral distribution during a flu pandemic, including a nod for establishing diverse alternative strategies and support for Web
    Antiviral research and Neutron Star System behaviours earn BC students ... - Canada NewsWire (press release)
    Antiviral research and Neutron Star System behaviours earn BC students
    Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com
    Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody
    Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)
    Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs
    New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
    New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation
Live support Online Chat


Our billing is certified by
Secure shopping certificates